Lunch & Learn with Curare Swiss AG

Switzerland Innovation Park Basel Area is organizing this learning session with Curare Swiss AG, one of our resident companies, supporting biotech companies in the translation of their therapeutic assets from the nonclinical phase to clinical Proof-of-Concept and beyond.

Join us for an insightful session where we will dive into the often-overlooked realm of clinical pharmacology studies with Noémie Hurst and Julien Beyrath, clinical and translational pharmacologists. Beyond the familiar safety and efficacy trials, studies such as TQT (Thorough QT), ADME (Absorption, Distribution, Metabolism, Excretion), and DDI (Drug-Drug Interaction) play a crucial role in drug development. Discover, through case studies, when and why these studies are required, and how optimizing early-stage trial design and planning can streamline your development pathway, potentially reducing costs and accelerating time to market. Perfect for innovators, scientists, and entrepreneurs looking to be introduced to the scope of clinical pharmacology in drug development.